Stay updated on Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The clinical trial record for pembrolizumab with chemotherapy and radiation therapy, with or without surgery, is displayed instead of an error page. It includes study details, participant criteria, outcomes, and a study protocol document.
    Difference
    75%
    Check dated 2026-11-10T21:53:03.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-11-03T22:00:36.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    An NIH announcement banner was added about the transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T21:50:59.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-06T21:47:36.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with basic HTML and a Home link, replacing the previous study-record content with an inaccessible page state.
    Difference
    23%
    Check dated 2026-09-23T00:11:42.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The revision label on the page changed from v3.6.6 to v3.7.0, indicating a site-level update to the page's rendering or metadata. This update does not alter the study data or visible content.
    Difference
    0.0%
    Check dated 2026-09-16T00:08:23.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page.